Drawing for GLUCONOR

USPTO serial 75909097

GLUCONOR

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BRODY, DANIEL S
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GLUCONOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

BROOKS R BRUNEAU

BROOKS R BRUNEAU MATHEWS, COLLINS, SHEPHERD & GOULD PA100 THANET CIR STE 306PRINCETON, NJ 08540-3674UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF DIABETES AND COMPLICATIONS THEREOFACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 28, 2006MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 28, 2006ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 26, 2006EX4GSOU EXTENSION 4 GRANTED—
Apr 3, 2006EXT4SOU EXTENSION 4 FILED—
Apr 3, 2006MAILPAPER RECEIVED—
Feb 14, 2006DOCKASSIGNED TO EXAMINER—
Oct 28, 2005EX3GSOU EXTENSION 3 GRANTED—
Oct 13, 2005EXT3SOU EXTENSION 3 FILED—
Oct 13, 2005MAILPAPER RECEIVED—
Feb 24, 2005EX2GSOU EXTENSION 2 GRANTED—
Feb 24, 2005EXT2SOU EXTENSION 2 FILED—
Feb 24, 2005MAILPAPER RECEIVED—
Nov 8, 2004EX1GSOU EXTENSION 1 GRANTED—
Oct 12, 2004EXT1SOU EXTENSION 1 FILED—
Oct 12, 2004MAILPAPER RECEIVED—
Apr 20, 2004NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 27, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 7, 2004NPUBNOTICE OF PUBLICATION—
Nov 24, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 3, 2003CFITCASE FILE IN TICRS—
Oct 6, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 6, 2003MAILPAPER RECEIVED—
Sep 23, 2003CNSIINQUIRY AS TO SUSPENSION MAILED—
Jul 26, 2002DOCKASSIGNED TO EXAMINER—
Jul 17, 2002DOCKASSIGNED TO EXAMINER—
Mar 21, 2001CNSLLETTER OF SUSPENSION MAILED—
Oct 30, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 27, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2000DOCKASSIGNED TO EXAMINER—
Jun 22, 2000DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance